PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Department of Psychiatry and Neurosciences, CCM, Charitéplatz 1, 10117, Berlin, Germany.\', \'Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Department of Psychiatry and Neurosciences, CCM, Charitéplatz 1, 10117, Berlin, Germany; Psychiatrische Universitätsklinik der Charité im St. Hedwig-Krankenhaus, Berlin, Germany.\', \'Psychiatrische Universitätsklinik der Charité im St. Hedwig-Krankenhaus, Berlin, Germany; Akademie der Wissenschaften Berlin-Brandenburg, Germany.\', \'Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Department of Psychiatry and Neurosciences, CCM, Charitéplatz 1, 10117, Berlin, Germany; Psychiatrische Universitätsklinik der Charité im St. Hedwig-Krankenhaus, Berlin, Germany; Humboldt-Universität zu Berlin, Berlin School of Mind and Brain, Germany.\', \'Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Department of Psychiatry and Neurosciences, CCM, Charitéplatz 1, 10117, Berlin, Germany. Electronic address: felix.betzler@charite.de.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0955-3959(22)00004-410.1016/j.drugpo.2022.103582
?:hasPublicationType
?:journal
  • The International journal on drug policy
is ?:pmid of
?:pmid
?:pmid
  • 35093679
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • No party, no drugs? Use of stimulants, dissociative drugs, and GHB/GBL during the early COVID-19 pandemic.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all